MUC20は,MET/RAS/STING軸を通してピロプトーシスを調節することによって腎臓線維症を緩和します
Jiaxin Huang1, Zhoutong Chen1, Fengbo Zhong2
1Department of Urology, Children's Hospital of Fudan University, Shanghai, 201102, China.
Theranostics
|February 16, 2026
まとめ
ムシンMUC20は,RAS-STING-NLRP3経路を調節することにより,腎臓を線維症と細胞死から保護します. MUC20の喪失は腎臓損傷を悪化させ,腎臓疾患の治療標的としてMUC20を示唆しています.
科学分野:
- ネフロロジーは腎臓科
- 分子生物学は分子生物学である.
- 免疫学 免疫学とは
背景:
- ムキンは,炎症と腎臓機能障害に関与するグリコプロテインです.
- 腎損傷と線維症におけるトランスメブランミューシンMUC20の特定の役割は十分に理解されていません.
研究 の 目的:
- 腎臓線維症におけるMUC20の機能的意義を調査する.
- 腎損傷におけるMUC20の基礎となる分子メカニズムを解明する.
主な方法:
- 誘発性腎臓損傷のためのMuc20欠乏性マウスと管状上皮細胞モデルを使用した.
- タンパク質の相互作用,RAS活性化,cGAS-STINGシグナル伝達,NLRP3炎症体活性化を分析するために分子および生化学的技術を使用しました.
主要な成果:
- MUC20欠乏症は,腎臓線維症と管状細胞のピロプトーシスを悪化させた.
- MUC20はMETと相互作用し,RASの活性化を促進し,MUC20の欠如は,2'3'-cGAMP,cGAS-STINGの活性化,リソソーム損傷,カリウム流出,NLRP3炎症体の活性化の増加につながる.
- このカスケードは,ピロプトーシスと線維性進行を引き起こします.
結論:
- MUC20は腎臓の保護調節剤として作用し,RAS-cGAS-STING-NLRP3媒介のピロプトーシスと線維症を抑制する.
- MUC20シグナル伝達経路をターゲットにすることで,腎臓線維症と慢性腎臓病の潜在的な治療戦略を提示します.
さらに関連する動画
関連する概念動画
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


